Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience

JAMA Cardiol. 2017 Mar 1;2(3):341-343. doi: 10.1001/jamacardio.2016.5041.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Humans
  • Incidence
  • Michigan / epidemiology
  • Quality Improvement*
  • Stroke / epidemiology
  • Stroke / prevention & control*
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Warfarin